Molecular Characterization, Reactivation, and Depletion of Latent HIV (Q34263657)

1 August 2017

Molecular Characterization, Reactivation, and Depletion of Latent HIV (English)

1 reference

https://api.crossref.org/works/10.1016/S1074-7613(03)00236-X

11 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1074-7613(03)00236-X

11 March 2024

8

Jerome A Zack

1 reference

1 August 2017

Lianying Gao

4

1 reference

1 August 2017

Greg Bristol

5

1 reference

1 August 2017

David G. Brooks

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499116

11 March 2024

Dean H. Hamer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499116

11 March 2024

Philip A. Arlen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499116

11 March 2024

Christina M. R. Kitchen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499116

11 March 2024

Edward A. Berger

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499116

11 March 2024

language of work or name

English

0 references

publication date

1 September 2003

1 reference

full work available at URL

1 August 2017

http://www.cell.com/article/S107476130300236X/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499116

https://api.elsevier.com/content/article/PII:S107476130300236X?httpAccept=text/xml

11 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1074-7613(03)00236-X

https://api.elsevier.com/content/article/PII:S107476130300236X?httpAccept=text/plain

11 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1074-7613(03)00236-X

11 March 2024

1 reference

1 August 2017

19

1 reference

1 August 2017

3

1 reference

1 August 2017

413-423

1 reference

Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Reconsidering targeted toxins to eliminate HIV infection: you gotta have HAART

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

The challenge of viral reservoirs in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Generation of HIV latency during thymopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Therapeutic targeting of human immunodeficiency virus type-1 latency: current clinical realities and future scientific possibilities

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Latent reservoirs of HIV: obstacles to the eradication of virus

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Re-emergence of HIV after stopping therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Interleukin-7: from bench to clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Chimeric toxins targeted to the human immunodeficiency virus type 1 envelope glycoprotein augment the in vivo activity of combination antiretroviral therapy in thy/liv-SCID-Hu mice

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Toward HIV eradication or remission: the tasks ahead.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Effects of prostratin on T-cell activation and human immunodeficiency virus latency

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Development and applications of the SCID-hu mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Increased affinity and stability of an anti-HIV-1 envelope immunotoxin by structure-based mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Immunotoxins for targeted cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial).

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900236-X

7 January 2021

HIV-1 Tat protein promotes formation of more-processive elongation complexes

32

1 reference

https://api.crossref.org/works/10.1016/S1074-7613(03)00236-X

11 March 2024

Identifiers

1 reference

1 August 2017

1 reference